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Abstract
Background: Epidemiological studies suggest that allogeneic immunity may inhibit HIV-1 transmission from mother to
baby and is less frequent in multiparous than uniparous women. Alloimmune responses may also be elicited during
unprotected heterosexual intercourse, which is associated ex vivo with resistance to HIV infection.
Methodology/Principal Findings: The investigation was carried out in well-defined heterosexual and homosexual
monogamous partners, practising unprotected sex and a heterosexual cohort practising protected sex. Allogeneic CD4
+ and
CD8
+ T cell proliferative responses were elicited by stimulating PBMC with the partners’ irradiated monocytes and compared
with 3
rd party unrelated monocytes, using the CFSE method. Significant increase in allogeneic proliferative responses was
found in the CD4
+ and CD8
+ T cells to the partners’ irradiated monocytes, as compared with 3
rd party unrelated monocytes
(p#0.001). However, a significant decrease in proliferative responses, especially of CD8
+ T cells to the partners’ compared
with 3
rd party monocytes was consistent with tolerization, in both the heterosexual and homosexual partners (p,0.01).
Examination of CD4
+CD25
+FoxP3
+ regulatory T cells by flow cytometry revealed a significantly greater proportion of these
cells in the homosexual than heterosexual partners practising unprotected sex (p,0.05). Ex vivo studies of infectivity of
PBMC with HIV-1 showed significantly greater inhibition of infectivity of PBMC from heterosexual subjects practising
unprotected compared with those practising protected sex (p=0.02).
Conclusions/Significance: Both heterosexual and homosexual monogamous partners practising unprotected sex develop
allogeneic CD4
+ and CD8
+ T cell proliferative responses to the partners’ unmatched cells and a minority may be tolerized.
However, a greater proportion of homosexual rather than heterosexual partners developed CD4
+CD25FoxP3
+ regulatory T
cells. These results, in addition to finding greater inhibition of HIV-1 infectivity in PBMC ex vivo in heterosexual partners
practising unprotected, compared with those practising protected sex, suggest that allogeneic immunity may play a
significant role in the immuno-pathogenesis of HIV-1 infection.
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Introduction
Allogeneic immunity is the most potent natural immune
response, as is observed in rejection of foreign tissues or organ
transplants. However, natural allogeneic tolerance can be equally
robust, as is seen in maternal tolerance of the fetal paternal semi-
allogeneic HLA. These two reciprocal mechanisms have occupied
the central stage of immunology. The critical importance of
mature DC in immunity and immature DC in tolerance has been
well documented [1,2]. Interaction between HLA and TCR are
significantly affected by costimulatory molecules, cytokines and
chemokines. Immunoregulatory CD4
+CD25
+FoxP3
+ T cells
(Tregs) have greatly influenced the concept of suppression of
immune responses, and are known to inhibit autoimmune diseases
[3–5] and elicit transplantation tolerance [6,7]. In contrast,
CD40L expression by CD4
+ T cells interacts with CD40 on DC
[8], B cells [9] and CD8
+ T cells [10] and is a potent ligand
inducing diverse immune responses.
The present study was based on the hypothesis that allogeneic
stimulation of human monocyte derived DC may elicit in CD4
+ T
cells either immune responses, or tolerance identified by
expression of CD25
+FoxP3
+ regulatory cells. Alloimmune re-
sponses may inhibit HIV-1 transmission, as has been documented
in vertical transmission from mother to baby [11]. HIV-1 infection
is more frequent in uniparous than multiparous women [12].
Furthermore, alloimmune responses elicited during unprotected
heterosexual intercourse was significantly associated ex vivo with
resistance to HIV-1 infection [13]. Mucosal allogeneic responses
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application of allogeneic PBMC [14].
The first objective of this investigation was to study allogeneic
responses in homosexual and heterosexual couples practising
unprotected sex and to compare these between the two cohorts.
The second objective was to identify immunological criteria that
differentiated those practising unprotected and protected sex and
may have affected infectivity by HIV-1. Both cohorts showed
significant allogeneic proliferative responses of CD4
+ and CD8
+
T cells stimulated by the partners’ irradiated monocytes (one way
MLR), compared with 3
rd party unrelated monocytes. A small
proportion of partners’ cells however, showed tolerization of
CD4
+ and CD8
+ T cells. Examination of CD4
+CD25
+FoxP3
+ T
regulatory cells in the two cohorts revealed a significantly greater
proportion of these cells in the homosexual than heterosexual
partners and they were associated with the CD4
+ Tc e l l
proliferative responses. These immune responses must have
been elicited by the partners’ HLA stimulating lymphoid cells in
the rectal, vaginal and/or penile mucosa. Comparison of
heterosexual partners practising unprotected with those practis-
ing protected sex showed a smaller proportion of CD4
+ T cells
derived from the protected cohort being allo-immunized. Ex vivo
HIV-1 infectivity studies of PBMC suggest that allogeneic
immunized heterosexual subjects practising unprotected sex
m a yh a v ea c q u i r e ds o m ep r o t e c t i o nw h e nc o m p a r e dw i t ht h o s e
practising protected sex.
Results
Allogeneic Stimulation of CD4
+ and CD8
+ T Cells with DC
Induces T Cell Proliferative Responses and
CD4
+CD25
+FoxP3
+ Regulatory T Cells
Human PBMC were stimulated with unmatched monocyte-
derived DC, which differed at least by one allele, and with
autologous DC controls. The CD4
+ T cells were .95% pure and
the DC expressed cell-surface CD83, CD80, CD86 and CD40
molecules (data not presented). Allogeneic stimulation of CD4
+ or
CD8
+ T cells elicited conventional proliferative responses
(Figure 1A). Allogeneic stimulation induced in addition CD4
+
regulatory T cells. To establish optimal co-culture conditions to
generate CD4
+CD25
+FoxP3
+ T reg cells, preliminary studies of
the ratio of DC to CD4
+ T cells (1:2, 1:10, 1:20 and 1:100) were
examined and this was shown to be at 1:10 DC:CD4
+ T cell ratio
(data not presented). A time course of 1–7 days revealed that co-
culture of DC with T cells for 7 days resulted in a progressive
increase in T regs from 1.5(60.1)% on day 0, to 3.4(60.4)% on
day 2 (p=0.05), 5.1(60.8)% on day 4 (p=0.04), reaching a
maximal increase of 8.3(60.2)% on day 7 (p=0.001) (Figure 1B);
representative illustrations of flow cytometry are shown in
Figure 1D. The regulatory T cells were then examined for the
expression of CD40L, which in the steady state was found in
7.6(60.2)% CD4
+CD25
+FoxP3
+ T reg cells and 28.9(61.1)%
CD4
+CD25
+FoxP3
2 effector cells (not presented). Allogeneic
Figure 1. Allogeneic stimulation of T cell proliferation and CD4
+ T regulatory cell expression in vitro. (A) Stimulation of CD4
+ and CD8
+ T
cells proliferation by allogeneic DC (ratio 10:1), (B) Comparative time-course expression of CD4
+CD25
+FoxP3
+ T cells stimulated with allogeneic or
autologous DC; (C) reversal of CD40L expression in CD25
+FoxP3
+ Treg cells and CD25
+FoxP3
2 T effector cells; (D) representative illustration of (B), and
(E) representative illustration of (C); Au – autologous, Allo-allogeneic; *p,0.05, **p#0.01, ***p=0.001 in 3–4 independent experiments.
doi:10.1371/journal.pone.0007938.g001
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CD4
+ T cells showed an increase in CD40L expression in T reg
cells (p=0.066), but a significant decrease in CD40L
+ effector T
cells, from 13.662.7 to 3.061.1% (p=0.022) (Figure 1C);
representative illustration is presented in Figure 1E. Thus,
allogeneic stimulation of CD4
+ T cells upregulated the CD40L
+
Treg cells and downregulated the CD40L
+ T effector cells.
Putative In Vivo Allogeneic Immunization or Tolerization
following Unprotected Homosexual Intercourse
Allogeneic stimulation in vitro elicited both T cell proliferative
and regulatory CD4
+ T cells. In order to see if these findings could
be translated to a human model, we studied homosexual
monogamous partners practising unprotected sex for at least 1
year (Table 1). These were separated by medical staff skilled in
taking sexual histories into a receptive and insertive group. HLA-
A, B, C, DR, DP and DQ typing showed that all partners had at
least one mismatch consistent with an MLR response. The CD4
+
and CD8
+ T cell proliferative responses were examined between
the receptive and insertive partners, as well as each against an
unrelated third party monocytes. Analysis of the one way MLR
showed clearly that whilst in 17 subjects there was a higher
response to the partner’s monocytes than those of the 3
rd party, in
3 subjects the reverse was observed. The different responders were
separated into two groups: (1) partners showing higher MLR than
those with 3
rd party cells were classified as putative allo-
immunized and (2) the ones showing a lower MLR as putative
tolerized responses. Analysis of the CD4
+ T cells from the
receptive partner stimulated by the partner’s monocytes, com-
pared with those of 3
rd party cells showed a significantly higher
CD4
+ T cell proliferation stimulated by the partners’ than 3
rd
party cells (p=0.003). Similar results were found with the insertive
partners’ cells stimulated with the 3
rd party CD4
+ T cells
(p,0.0001). As there was no significant difference in the MLR
between the receptive and insertive subjects (p=0.122) we
combined them (mean 13.96sem 2.0%) and analysed against
the 3
rd party cells (5.061.2%). A significant increase in CD4
+ T
cell proliferation was found in the immunized subjects (p=0.0001;
Figure 2A). There were only 3 putative tolerized partners and they
showed a converse MLR response to the 3
rd party PBMC, which
was higher (12.364.8%) than that found with the partners’ PBMC
(1.461.4%), but the 5% level of significance was not reached,
which was probably due to the small number of subjects
(Figure 2A). However, the difference between the immunized
(13.962.0%) and tolerized (1.461.4%) CD4
+ T cells was
significant (p,0.0001). We have analyzed the MLR against the
number of episodes of unprotected sexual intercourse over the past
year by plotting each subject with reference to the allo-immune or
tolerance response. None of the 3 cohorts showed any correlation
between these parameters. We have similarly plotted the time of
last intercourse against MLR, which also failed to show any
correlation.
A similar analysis was pursued with the CD8
+ T cells, which
showed the combined CD8
+ T cell proliferative response
(partners A and B) between the immunized partners was
significantly greater (31.064.7%) than the corresponding re-
sponses to the 3
rd party PBMC (4.961.8%, p=0.001) (Figure 2B).
Conversely, the putative tolerized partners showed significantly
lower CD8
+ T cell proliferative responses (17.765.6%) than those
elicited by the 3
rd party cells (28.166.0%, p=0.004; Figure 2B).
However, unlike with the CD4
+ T cells, the proportion of
immunized (31.064.7%), compared with tolerized CD8
+ Tc e l l s
(17.765.6%) failed to reach the 5% level of significance
(p=0.088). Altogether the results suggest that homosexual
intercourse may elicit mostly immune CD4
+ Tc e l lp r o l i f e r a t i v e
responses (17 out of 20 partners), compared with 9 out of 20
yielding CD8
+ T cell proliferation. A decrease in CD4
+ T cell
proliferation, consistent with tolerization was found only in 3 out
of 20 partners, but was greater with CD8
+ T cells (8 out of 20
partners, the remaining 3 showing no change).
Putative In Vivo Allogeneic Immunization or Tolerization
following Unprotected Heterosexual Intercourse
A similar analysis of PBMC from heterosexual subjects
practising unprotected sex stimulated with the partners’ monocytes
showed a significantly higher proportion of responding cells to the
partners’ (12.561.7%) than those of 3
rd party cells (4.961.3%,
p=0.001) (Figure 3A, Figure S1A). Conversely, an increase in
CD4
+ T cell proliferation was found in the proportion responding
to partners’ cells (2.161.1), compared with those to the 3
rd party
irradiated cells (17.663.4) in the putative tolerized cells (p=0.049,
Figure 3A). However, unlike in the homosexual partners, 6 of the
20 heterosexual couples showed no change (62%) in their MLR.
CD8
+ T cells yielded comparable results but with a larger number
of putatively tolerized subjects (6 instead of 3), as was also noted in
the homosexual cohort. A significant increase (p,0.0001) was
found in CD8
+ T cell proliferation stimulated by the partners’ cells
(13.962.0%) compared with 3
rd party cells (7.161.6%) in the
immunized couples and the converse was found in the tolerized
couples (17.466.6% and 35.869.1%, respectively; p=0.009;
Figure 3B, Figure S1B). It is noteworthy that whereas the CD4
+
T cells showed a significant increase (p=0.0001) in the allo-
immunized (12.561.7%) compared with the tolerized couples
(2.161.1%), this was not found with the CD8
+ T cells (13.962.0
compared with 17.466.6%, respectively; Figure 3A, B).
Heterosexual Partners Practising Protected Sexual
Intercourse
A further cohort of 16 heterosexual subjects (8 partners) were
recruited practising condom protected sexual intercourse. Of the
16 subjects only 5 were immunized (p=0.045), 4 tolerized
(p=0.036) and 8 showed no change in the CD4
+ T cell
proliferative response (data not presented), when stimulation with
the partners’ monocytes were compared with those of 3
rd party
cells (Figure 3C, Figure S2A). The corresponding CD8
+ T cells
also showed significant immunization in 7 (Figure 3D, p=0.045)
and tolerization in 8 subjects (Figure 3D, Figure S2B, p=0.002).
However, comparison of CD4
+ T cells proliferation in the
immunized heterosexual cohort of 11/19 subjects practising
unprotected sex with 5/16 practising protected sex or the tolerized
cohort, as well as the CD8
+ T cells in the corresponding cohorts
failed to reach the 5% level of significance.
Table 1. Description of the 3 cohorts of uninfected partners
practising unprotected or condom-practised sex.
Group
Sexual
Practice Gender
Number of
Subjects
Mean Age
(Years)
1. Unprotected sex Homosexual Male 20 30.8561.88
2. Unprotected sex Heterosexual Female 10 24.461.23
Male 10 24.261.3
3. Protected sex Heterosexual Female 9 27.361.1
Male 9 29.561.15
doi:10.1371/journal.pone.0007938.t001
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+FoxP3
+ Regulatory T Cells
CD25
+FoxP3
+ regulatory CD4
+ T cells were identified by triple
immunofluorescence flow cytometry with mAb to CD4, CD25
and FoxP3 antigens. A significant increase in the T regulatory cells
(p=0.013) was found in the cells from homosexual subjects,
practising unprotected sex when stimulated with the partners’ cells
(6.660.9%), compared with the 3
rd party cells (4.060.5%;
Figure 2C). The 2 putatively tolerized subjects could not be
analyzed statistically, but showed a mean of 4.0 and 3.6%,
respectively. Analysis of CD25
+FoxP3
+CD4
+ T cells from the
unprotected heterosexual couples showed no difference between
the partners’ and 3
rd party stimulated cells (5.161.0 and
5.860.9%, respectively (Figure 3E). Although the proportion of
T regs in the tolerized couples was higher (5.162.1%) within the
partners’ cells than those of the 3
rd party stimulated cells
(3.961.7%), this was not significant, possibly due to the small
number (n=3) of tolerized subjects (data not presented).
Immunization was significantly more frequent in the homosexual
(14/16) than hetero-sexual cohorts (8/16, p=0.029), but no
difference was found among the tolerized groups (p=0.626). We
have compared the T regulatory cells against the number of
episodes of unprotected sexual intercourse for each subject in the 3
cohorts and found no correlation between these parameters.
A significant association between the CD4
+ T cell MLR and T
regs was found in the immunized homosexual (p=0.007)
(Figure 4A) and heterosexual (p=0.002) subjects (Figure 4B),
suggesting that the MLR may be regulated by the
CD4CD25FoxP3
+ T cells. The results were also significant when
CD4
+ T regs (6.660.9%) were compared with CD8
+ T cell MLR
(31.064.7%), both for the homosexual (p=0.001) and heterosex-
ual cohorts (5.161.0% and 13.962%, respectively, p=0.002).
The tolerized cohorts, however, failed to show any of the above
associations.
CD4
+ IFN-c
+ Th1 Cells
There was no significant difference in the percentage of IFN-c
producing CD4
+ T cells within the PBMC population stimulated
by the partners’ cells compared with 3
rd party cells in the
homosexual (Table 2.1) or heterosexual unprotected or protected
partners (Table 2.2, 2.3). Furthermore, no association was
observed between CD4
+ T cell proliferation and IFN-c producing
CD4
+ T cells either in the cells of homosexual or heterosexual
Figure 2. CD4
+ T cell proliferation and regulatory cell expression in homosexual partners. Analysis of the proliferative responses of T cells
isolated from homosexual subjects practising unprotected intercourse after stimulation with partner or 3rd party monocytes. Allo-immunized or
tolerized (A) CD4
+ T cells and (B) CD8
+ T cells; 3 subjects showed no change. (C) Percentage of CD25
+CD4
+FoxP3
+ T reg cells and (D) percentage of
IFN-c in CD4
+ cells of allo-immunized subjects after stimulation with partner or 3rd party monocytes. (E) Representative illustration of CD4
+ and CD8
+
T cell proliferation data from an allo-immunized subject in (A) and (B), including autologous controls which were subtracted from values shown in (A)
and (B). (F) Representative illustration of data in (C); *p#0.01, **p=0.001, ***p,0.0001.
doi:10.1371/journal.pone.0007938.g002
Allogeneic Immunity
PLoS ONE | www.plosone.org 4 November 2009 | Volume 4 | Issue 11 | e7938unprotected or protected cohort (Table 2.4–2.6). However, a
significant association was found between CD4
+ T regs and IFN-c
producing cells in homosexual immunized subjects (p=0.048)
(Table 2.7), though this was more pronounced when stimulated
with 3
rd party cells (p=0.007). In heterosexual unprotected or
protected subjects CD4
+ T regs and IFN-c producing cells failed
to show a significant association (Table 2.8 and 2.9), although they
showed a similar trend. The lack of statistical significance might be
due to smaller number analysed (8 and 4, respectively). Attempts
were made to study Th17 cells by means of IL-17 assay, but the
results showed very low proportion of cells (,1%) and enhancing
IL-17 with cytokines was not pursued, as this would affect the
steady state of the cells. IL-4 also failed to show any changes in the
3 cohorts examined.
In vitro HIV-1 Infectivity
PBMC were stimulated with PHA and IL-2 for 3 days, the cells
were then infected with serial dilutions of HIV-1 (BaL), cultured
up to 9 days and p24 was then assayed. Analysis of the
heterosexual partners practising unprotected sex (9.5 median of
50% inhibition of virus) compared with those practising protected
sex (145 median) showing a significant increase in virus dilution
required for the PBMC to inhibit the virus (Figure 5; p=0.0288).
The corresponding data in the homosexual subjects practising
unprotected sex are not presented as a cohort practising protected
sex was not available to pursue analysis with those practising
unprotected sex. The results suggest that heterosexual subjects,
practising unprotected sex who were allo-immunized may have
acquired some protection to HIV-1 infection, as compared with
those practicing protected sex. We then analysed any association
between in vitro HIV-1 infectivity and the immunological
parameters tested. No significant relationship was established with
CD4
+ T cells proliferation or with IFN-c (Table 3.1 and 3.2).
However, the proportion of CD4
+CD25
+FoxP3
+ T reg cells was
significantly associated with HIV infectivity in the homosexual
(p=0.011), heterosexual unprotected (p=0.040) and protected
(p=0.030) cohorts (Table 3.3). These results suggest that T regs
may affect the infectivity of PBMC in all 3 cohorts.
Analysis of HLA and CCR5 Polymorphism
There was no discernable difference in the HLA-A, B, C, DR or
DQ alleles between the 3 cohorts. However, HLA-B27 was found
in 5 immunized and none of the tolerized CD4
+ T cell
proliferative responses, whereas HLA B35 was identified in 2
tolerized, 2 immunized and 1 unchanged response. Although the
total number of B27
+ and B35
+ subjects was too small for statistical
analysis, the results are consistent with HLA B27 being associated
with slow progression, and possibly HLA B35 with rapid
Figure 3. CD4
+ T cell proliferation and regulatory cell expression in heterosexual partners practising unprotected or protected sex.
Analysis of the proliferative responses of T cells isolated from heterosexual partners practising either unprotected or protected sexual intercourse; the
T cells were stimulated with the partners’ or 3rd party monocytes. Allo-immunization or tolerization of (A) CD4
+ T cells and (B) CD8
+ T cells in
heterosexual subjects practising unprotected sex (5 in each showed no change); (C) and (D) in those practising protected sex; 8 and 3 showed no
change, respectively. (E) and (F) Percentage of T reg cells in the two respective cohorts; *p,0.05, **p,0.01, ***p=0.001, ****p,0.0001.
doi:10.1371/journal.pone.0007938.g003
Allogeneic Immunity
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+ T regulatory or IFN- -c producing cells related to the proliferative responses. Homosexual and heterosexual cohorts
practising unprotected sex analysed for the relation (A) and (B) between CD4
+ T cell proliferation and Treg cells; (C) and (D) CD4
+ T cell proliferation
and IFN-c; **p#0.01.
doi:10.1371/journal.pone.0007938.g004
Table 2. IFN-c expression in CD4
+ T cells of immunized
homosexual and heterosexual partners practising
unprotected or protected sexual intercourse.
IFN- -c in CD4
+ T cells (%)
Sexual Intercourse Immunization
No./Total Partners 3rd Party
1. Homosexual (unprotected) 17/20 11.3(2.4) 10.7(2.2)
2. Heterosexual (unprotected) 9/18 9.6(2.0) 10.6(2.0)
3. Heterosexual (protected) 4/18 8.8(1.8) 9.0(2.4)
(n) Proliferation IFN- -c
4. Homosexual (unprotected) (12) 14.4(2.3) 11.3(2.4)
5. Heterosexual (unprotected) (8) 12.5(1.7) 9.6(2.0)
6. Heterosexual (protected) (4) 8.8(1.8) 9.0(2.4)
(n) T regs IFNc
7. Homosexual (unprotected) (12) 6.6(1.0) 11.3(2.4)*
8. Heterosexual (unprotected) (8) 5.1(1.0) 9.6(2.0)
9. Heterosexual (protected) (4) 5.7(1.0) 8.8(1.8)
The results are presented as mean (6sem); *p,0.05.
doi:10.1371/journal.pone.0007938.t002
Figure 5. HIV-1 infectivity in heterosexual partners practising
unprotected or protected sex. Multiplicity of infection of HIV-1 (BaL)
required for the 50% inhibitory effect of PBMC from allo-immunized
heterosexual partners (A N and B o) practising unprotected or protected
sex (n=16 and 12, respectively); *p=0.028.
doi:10.1371/journal.pone.0007938.g005
Allogeneic Immunity
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individuals expressed HLA-B57 which is also associated with slow
progression to AIDS. Sharing of HLA-class II was not sufficient to
account for the tolerant group, as all partners showed an HLA-
class II mismatch with the DR and DQ alleles, which would
generate an MLR response. Heterozygous CCR5 deletions were
found in 5 of the heterosexual unprotected and 4 protected
subjects. Homozygous but not heterozygous deletion was found
only in 1 of the homosexual subjects. There was no obvious
difference in infectivity in those with or without CCR5 deletion, or
in immunized and tolerized subjects.
Discussion
Allogeneic stimulation of T cells in vitro elicited not only CD4
+ and
CD8
+ T cell proliferative responses, but also CD4
+CD25
+FoxP3
+ T
regulatory cells. A comparative study between allogeneic and
autologous stimulation of DC showed significant upregulation of
CD4
+CD25
+FoxP3
+ T regulatory cells by day 2 and reaching an
optimum by day 7. Co-culture of allogeneic stimulated DC with
autologous CD4
+ T cells induced a greater proportion of
CD4
+CD25
+FoxP3
+ T reg cells expressing CD40L, whereas the
reverse was found with the CD4
+CD25
+FoxP3
2 effector T cells.The
effect of allostimulation upregulating CD40L on T reg cells, in
contrast to downregulating CD40L on CD4
+ Te f f e c t o rc e l l si s
challengingandsuggestsanenhancedinteractionofallo-stimulatedT
reg cells with CD40 molecules on DC, which may be re-activated
thus maintaining their function. Down-regulation of CD40L on
CD4
+ T cells is consistent with skin transplant tolerance induced by
neutralizing CD40L function [6].
The preliminary allogeneic studies in vitro were followed by
potential mucosal allogeneic responses in vivo. Unprotected hetero-
sexual intercourse has been shown in PBMC to elicit predom-
inantly allogeneic immunization and to a limited extent toleriza-
tion.
13 Here we have studied both heterosexual and homosexual
intercourse, and have examined allogeneic immunity and putative
tolerance expressed by CD4
+ and CD8
+ T cell proliferative
responses and T regulatory cells. The results clearly demonstrate
highly significant CD4
+ and CD8
+ T cell allogeneic immunization
in partners practising unprotected homosexual (p,0.0001 and
p=0.001) or heterosexual (p=0.001 and p,0.0001) intercourse,
respectively. However, whilst tolerization of CD4
+ T cells was
found only in 3/20 homosexual and 3/19 heterosexual partners,
the CD8
+ T cells were tolerized in 8/20 homosexual partners
(p=0.004) and in 6/20 heterosexual subjects (p,0.009). Alto-
gether the CD8
+ T cell responses were higher than those of CD4
+
T cells, and CD8
+ T cells were more likely to be tolerized than
CD4
+ T cells in both types of unprotected sexual activities. The
mechanism governing these findings will need to be explored. As
there was an HLA-class II mismatch of the DR and DQ alleles,
which would generate MLR responses, sharing of HLA-class II
would not account for the tolerance.
Heterosexual subjects practising condom-protected sex were
then analysed and although they also showed significant increase
in CD4
+ (p=0.045) and CD8
+ (p=0.045) T cell proliferation,
these were of considerably lower order of significance than those
recorded in the unprotected cohorts (p=0.001 and p,0.0001,
respectively). The proportion of CD4
+ T cells in the allogeneic
immunized protected partners was also smaller (5/16) than those
in the unprotected partners (11/19). The tolerized subjects showed
significant increase in CD4
+ T cell proliferation (p=0.036), unlike
those in the unprotected cohort, but the tolerized CD8
+ T cells
showed comparable levels of significance in the 2 cohorts.
To interpret the effect of unprotected rectal and vaginal
intercourse on allogeneic immunity and tolerance we studied
CD4
+CD25
+ FoxP3
+ regulatory T cells [15]. These were
significantly increased in the allo-immunized homosexual
(p=0.013) but not hetero-sexual cohorts (p=0.440). The
homosexual cohort (14/16) also showed a significantly higher
proportion of T regs (p=0.029) than the heterosexual cohort (8/
16). The increased propensity of T reg cells being elicited through
the rectal mucosa in homosexual men, in contrast to the cervico-
vaginal mucosa in heterosexual women is an intriguing finding.
This might be related to the involvement of two diverse mucosal
tissues; the fragile single cell columnar epithelium of the rectum
lacking Langerhans cells, compared with the stratified squamous
vaginal epithelium with large number of Langerhans cells.
The overall aims were to study the 4 types of T helper cells; Th1
(IFN-c), Th2 (IL-4 and IL-10), Th17 (IL-17) and T regulatory
cells. Surprisingly IFN-c showed no significant changes in the
allogeneic immunized or tolerized homosexual or heterosexual
partners and there was no significant association between IFN-c
and CD4
+ T cell proliferation. This was found both in CD4+ T
cells by flow cytometry and testing CD4
+ T cell culture
supernatants by the Luminex bead technique (results not
presented). IL-4 and IL-10 assays showed very low concentrations,
suggesting that Th2 cells do not play a major role. Th17 cells
showed very low levels (,1%), which were not amenable to
Table 3. Association between multiplicity of infection of HIV-1 (BaL) required for the 50% inhibitory effect of PBMC (Infectivity)
and the proliferative response, percentage of IFNc produced and CD25
+FoxP3
+ T cells (T regs) of CD4
+ T cells; analysis by Mann
Whitney test.
Homosexual (Unprotected) Heterosexual (Unprotected) Heterosexual (Protected)
1) (n) Infectivity CD4 prolif. 1) (n) Infectivity CD4 prolif. 1) (n) Infectivity CD4 prolif.
Median (16) 62.5 15.5 (8) 8 12.0 (4) 40 16.2
p=0.0135 p=0.4945 p=0.1939
2) Infectivity IFN-c 2) Infectivity IFN-c 3) Infectivity IFN-c
Median (12) 25 11.4 (8) 8 7.9 (4) 40 11.3
p=0.2848 p=0.4945 p=0.3123
3) Infectivity T regs 2) Infectivity T regs 2) Infectivity T regs
Median (14) 40 6.3 (8) 8 5.0 (4) 40 6.7
p=0.0030 p=0.040 p=0.0304
doi:10.1371/journal.pone.0007938.t003
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with cytokines, such as IL-1b and IL-6 [16]. CD8
+ T reg cells were
not studied, but CD4
+ T regs may have inhibited CD8
+ T cell
proliferative responses, as the combined homosexual and hetero-
sexual tolerized cohorts showed an inverse correlation between the
two types of cells, though the 5% level of significance has not been
reached (r=0.553, p=0.062).
Mucosal allogeneic immunization and tolerance has received
limited attention, though the importance in mucosal infections,
especially of the genital tract, is evident. Ejaculates contain CD4-
positive T cells, macrophages, neutrophils, immature germ cells
[17], epithelial cells that express HLA antigens, and cell-free HLA
antigens [18]. Furthermore, HIV-1 contains host HLA class I and
II antigens [19,20]. Multiparous females may be allo-immunized
by the paternal semi-allogeneic fetus and they are less prone to
HIV-1 infections than uniparous or non-parous females [12]. This
has also been observed in multiparous female macaques [14]. Both
rectal and vaginal exposure to allogeneic antigens during
homosexual and heterosexual intercourse, respectively may elicit
immunity and to a lesser extent tolerance to the monogamous
partners demonstrated in this paper but the effect of multiple
partners in a general population will need to be explored.
However, a cohort of sero-negative female sex workers, exposed to
multiple partners in Cote d’Avoire showed suppression of
alloimmune responses [21].
Overall it is noteworthy that unlike in heterosexual unprotected
partners, in whom 11/19 showed evidence of significant increase
in MLR of CD4
+ T cells, 3/19 a decrease and 5/19 showed no
change, the corresponding data for the protected partners were 4/
16, 4/16 and 8/16, respectively. The higher proportion of
allogeneic CD4
+ T cell immunized and smaller number of
unchanged MLR that were observed among the unprotected
compared with protected heterosexual cohorts, is consistent with
increased immune activation in those practising unprotected sex.
However, this was not found in the CD8
+ T cells. Furthermore, a
larger proportion of CD4
+ T reg cells was found in the allogeneic
immunized homosexual partners (14/16–88%), compared with
the heterosexual partners (8/16–50%; p=0.029), both cohorts
practising unprotected sex.This was not found in heterosexual
partners practising protected sex.
Ex vivo HIV-1 infectivity studies suggest that allo-immunized
heterosexual subjects practising unprotected sex may have
acquired some protection to HIV-1 infection, as a significantly
lower dilution of virus was inhibited by their PBMC, compared
with those practicing protected sex (p=0.028). A similar analysis
of homosexual partners practising unprotected sex could not be
pursued, as homosexual partners practising protected sex for a
period over 1 year could not be recruited with any confidence. We
then analysed any association between in vitro HIV-1 infectivity
and the immunological parameters tested in the 3 cohorts. HIV-1
infectivity showed significant association with the T reg cells in all
3 cohorts (p,0.05 or p,0.01), but not with CD4
+ T cell
proliferation or IFN-c production. As T reg cells were significantly
associated with CD4
+ T cell proliferation both in homosexual
(p=0.015) and heterosexual (p=0.010) unprotected cohorts, the
data support the concept that T reg cells play a regulatory role in
allogeneic stimulation and HIV-1 infectivity of CD4
+ T cells. We
have not studied further the mechanism involved, but the T reg
cells may inhibit CD4
+ T cell activation and thereby infectivity of
these cells. Indeed, there is evidence that allogeneic mediated T
reg cells are efficient in suppressing transplantation responses [22].
Restriction factors such as the innate anti-HIV-1 APOBEC3G is
upregulated on allo-stimulation and may be involved in inhibition
of HIV-1 [23].
Materials and Methods
Recruitment of Volunteers
Permission forthis investigationwasgrantedandapproved bythe
Kings College Research Ethics Committee. Informed written
consent was obtained from all participants. Recruitment was begun
initially using a wide number of avenues, including mass-email
requests through our host institutions of Guys and St Thomas’
Hospitals and Kings College London, approaching asymptomatic
patients seeking screening at sexually transmitted disease (STD)
clinics and from members of the public who responded to
advertisements. As no individuals from STD clinics met the criteria,
we stopped using this avenue early on. Volunteers were excluded if
they had a history of sexually transmitted or major infectious
disease, at least a year prior to entry into the study. Patients were
excluded if they were pregnant, or had been pregnant within 12
months of entry into the study. Patients were also excluded if they
had any recent (within 12 months) severe illness, or if they had any
chronic condition thought possibly to influence the study findings
(eg diabetes, chronic viral hepatitis, conditions requiring steroid
usage or chronic therapies, etc). This screening excluded patients
who had blood transfusion within the past 12 months. We have not
dealt in more depth with previous blood transfusions, as whole
blood whichmayinducealloimmuneresponseshasnotbeen used in
the UK over the past 11 years. As the mean age of our heterosexual
‘‘unprotected’’ cohort was 24.361.2 and the homosexual cohort
30.861.8, it is unlikely that a significant number would have had
bloodtransfusionsand ofthosethatmighthavebeentransfused only
about 2% develop alloimmune response. Subjects known or
suspected to be HIV antibody positive were excluded and were
only included if they were low risk for HIV infection or if they had a
negative HIV antibody test within the previous 12 months. We
enrolled three cohorts, all of which were monogamous, defined as
partners that had no other sexual partners in terms of oral, anal or
vaginal sex, whether protected or unprotected by means of barrier
methods for the 12 months prior to enrollment in the study and for
the duration of their participation in the study.
Group 1. Homosexual monogamous men practising
unprotected sexual intercourse (10 couples, n=20); these were
men having sex with men (MSM). The criteria for entry to this
group were men having unprotected penetrative anal intercourse
with the same male partner for at least the past 12 months. The
partners in this group were only included if there was a clear
history of them having had unprotected anal sex within this
relationship, and no unprotected oral or anal sex with other
partners within the previous 12 months. In addition, within this
group, we recorded whether the individuals practised
predominantly receptive (passive) intercourse, predominantly
insertive (active), or a roughly equal mixture of both.
Group 2. Heterosexual monogamous partners practising
unprotected sexual intercourse (10 couples, n=20). The criteria
for this group were that the couples were in a monogamous
heterosexual relationship, otherwise the criteria were the same as
for the MSM group.
Group 3. Heterosexual monogamous partners practising
protected sexual intercourse (9 couples, n=18). The criteria for
this group were that the couples were in a monogamous
heterosexual relationship, but that any act of sexual intercourse
over the previous 12 months, including oral sexual intercourse,
was practised using barrier contraception.
The sexual history for all patients for all groups was taken by
nurses experienced in sexual health and sexual history taking.
Great care was taken, using open questioning, recording in
private, and assurance of anonymity, in order to capture an
Allogeneic Immunity
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intercourse were entered onto a structured written questionnaire
for all subjects. This enabled data, such as the interval between the
last intercourse and the time when the blood specimen was taken
for this investigation to be evaluated.
Isolation of Peripheral Blood Mononuclear Cells CD14
+
Monocytes and Preparation of Immature DC
Approximately 40 mls of blood was collected from each
participant into EDTA filled tubes. Peripheral blood mononuclear
cells (PBMC) were isolated by centrifugation of blood on a Ficoll-
Hypaque density gradient (Amersham Biosciences, Little Chalfont,
Bucks, UK). CD14
+ monocytes were enriched by depletion of
CD14
- cells using a Monocyte Isolation Kit (MACS; Miltenyi
Biotec). The purity of isolated monocytes was consistently greater
than 90% when analyzed by flow cytometry with antibodies to
CD14 (BD Biosciences). CD14
+ monocytes were cultured in GM-
CSF (1000 U/ml) and IL-4 (40 U/ml) supplemented medium for
4–5 days to differentiate into immature dendritic cells.
Mixed Lymphocyte Response (MLR)
To examine whether unprotected sex resulted in allo-immuni-
zation or allo-tolerization, CFSE labelled PBMCs (responders),
made up to 2610
5/ml in supplemented RPMI culture medium,
containing 200 mMol glutamine, 100 mg/ml penicillin and
streptomycin and 10% FBS, from each partner were co-cultured
in 96 well plates. One way MLR were set up with autologous,
allogeneic or unrelated (third party) monocytes (stimulators), made
up to 1610
6/ml in supplemented RPMI culture medium. The
cultures were incubated at 37uC for 7 days. At day 7 day
supernatants from the cultures were harvested for cytokine
analysis. Repeated tests with the cells from the same subjects
stimulated with the partner’s monocytes compared with 3
rd party
cells showed differences in percentages but the pattern of response
remained the same with reference to 3
rd party cells.
For intracellular cytokine and CD25
+CD4
+FoxP3
+ regulatory T
cell analysis, unstained PBMCs (responder cells) were co cultured
with autologous, allogeneic or unrelated (third party) monocytes
(stimulators) in 96 well plates and incubated at 37uC for 7 days.
For in vitro analysis of T cell proliferation to alloantigens, CFSE
labelled PBMCs (responders), made up to 2610
5/ml in supple-
mented RPMI culture medium, were co-cultured in 96 well plates
with 1610
6/ml autologous or allogeneic immature DC. The
cultures were incubated at 37uC for 7 days.
CFSE Labelling of PBMC and Flow Cytometric Analysis to
Determine the Proliferative Responses of CFSE Labelled
CD4
+ and CD8
+ T Subsets
PBMCs were suspended in pre-warmed PBS supplemented with
0.1% BSA at a final concentration of 1610
6 cells/ml. Aliquots of
2 ml/ml of 0.05 mM of CFSE (Invitrogen) were added to make a
final working concentration of 1 uM and the cells were incubated
for 10 minutes at 37uC. Staining was quenched by adding 5
volumes of ice cold RPMI to the cells, and then by incubation for 5
minutes on ice. The cells were then washed 3 times with RPMI
and counted.
To determine the proliferative responses of both CD4
+ and
CD8
+T cells after 7 days of allostimulation, CFSE labelled cells
were surface stained with antibodies to CD4 (APC-CY7)
(BDBiosciences) and CD8 (APC) (BD Biosciences) at a 1:100
dilution for 30 minutes at 4uC. After washing in PBS, cells were
analysed by flow cytometry using a BD FACSCanto
TM II, using
the software DIVA.
Intracellular Cytokine Staining for IFN-c and IL-4 in CD4
+
T Cells
To determine intracellular cytokine production, cultured cells
were stimulated with 5 ng/ml PMA (Sigma), 0.5 mg/ml ionomy-
cin (Sigma) and 0.7 mg/ml golgi stop (BD Biosciences) for 4 hours
at 37uC. After washing with PBS, the cells were surface stained for
20 minutes at room temperature with 5 ml of an antibody to CD4
(APC) (BD biosciences) and 0.4 mg/ml of Live/Dead Fixable
Near-IR (Invitrogen) to distinguish between dead and live cells.
After washing twice with PBS, the cells were fixed with 100 ml/
well IC fixation solution (eBioscience) and incubated for 20
minutes at room temperature. Cells were washed twice with 1x
permeabilization buffer (eBiosciences). For intracellular staining,
cells were incubated with 5 ml/well of IFN-c (FITC) and 5 ul of
IL-4 (PE) (BD Biosciences) for 20 minutes at room temperature.
After washing twice in 1x permeabilization buffer cells were
analysed by flow cytometry as described above.
Flow Cytometric Detection of CD4
+CD25
+FoxP3
+
Regulatory T Cells
For cell surface staining, the cells were incubated with 5 mlo f
conjugated antibodies to CD4 (FITC) (BD Biosciences), CD25
(APC) (eBiosciences) for 30 minutes at 4uC.
For intracellular staining for the regulatory cell marker FoxP3,
cells were washed in cold PBS, and 1 ml of freshly prepared
Fixation/Permeabilization buffer (eBiosciences) was added to the
cells, which were then vortexed and incubated for 30 minutes at
4uC. After washing twice with 2 ml 1X permeabilization buffer,
cells were blocked using 2% normal rat serum for 15 minutes at
room temperature. After the blocking step, cells were incubated
with 10 ml of either anti-human FoxP3 (PCH101) or rat IgG2a
isotype control for 30 minutes at 4uC. After washing with 1 ml of
1X permeabilization buffer, cells were analysed by flow cytometry
as described above.
Flow Cytometric Analysis of Cell Surface CD40L
Expression on Regulatory and Effector T Cells after Co-
Culture with Allogeneic or Autologous Immature DC
CD4
+ T cells (2610
6/ml) were cultured with allogeneic or
autologous immature DC (2610
5/ml) for 7 days in 96 well plates
at 37uC. For CD40L staining or isotype control staining (IgG1, BD
Biosciences), Golgistop (0.7 ml/ml, BD Biosciences) was added
10 hours before termination of the co culture. Cells were then
stained and analysed by flow cytometry as described above. To
differentiate between CD4
+ Tregs and CD4
+ effector T cells
CD4
+CD25
+ T cells were gated according to the presence and
absence of FoxP3 expression, respectively.
HIV Infectivity of PBMCs
To test HIV-1 infection, PBMCs were activated with 10 mg/mL
of PHA (phytohaemagglutinin, Sigma) in supplemented RPMI for
3 days then washed with medium and cultured in supplemented
RPMI with 20 IU interleukin 2 (Schiaparelli Biosystems BV,
Woerden, Netherlands) overnight. Serial dilutions of primary
HIV-1 strain BaL (CCR5-binding strain) were prepared with a
starting concentration of 20 ng/100 ml of p24. Aliquots of
0?6610
6 cells were infected with serial dilutions of 1:10
21 to
1:10
24 multiplicity of HIV-1 strains for 3 h. The cells were washed
three times with medium and cultured in triplicates at 1610
5 per
well in 96-well culture plates. Every 2 days, 100 mL of culture
supernatant was replaced with 100 mL of medium supplemented
with 20 IU interleukin 2. On day 8, the cell-free culture
supernatant was assayed, with HIV-1 p24 Antigen ELISA
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cells with HIV-BaL strain was presented as the multiplicity of
infection which inhibits 50% of the virus in PBMC.
HLA Typing and CCR5 Polymorphism
DNA was extracted from PBMC using DNA isolation kit
(Promega, Southampton, UK) according to the manufacturer’s
instruction. The purified DNA was stored at 220uC. HLA class I
and II typing for HLA-A, -B, -C, -DRB and –DQB1 was carried
out by the PCR technique with sequence specific primers; the
primer sequences used have been previously reported. [24,25]
PBMC showing a mismatch at more than one allele was used for
allostimulation. The D32 CCR5 polymorphism was determined
by modified PCR with sequence specific primers, with the primer
59-TCA TCA TCC TCC TGA CAA TCG- 39 and the antisense
primer 59 –CCA GCC CCA AGT TGA CTA TC-39. [26] The
PCR products were separated on a 2% agarose gel to maximise
the separation between the wildtype (262 bp) and deletion
(230 bp) products.
Statistical Analysis
For parametric data the results were expressed as mean (6sem)
and student’s paired or that for two means was used. For non-
parametric data the Mann-Whitney test was used. The Chi square
test was applied for analysis of associations, and Fisher exact test
for cells with small frequencies. Inter-group analyses between the 3
cohorts using Student’s t test for two means mostly showed no
significant differences as it was apparent that there were two
populations – putative allogeneic and tolerogenic – that yielded
opposite responses when stimulated with the partner’s monocytes
and compared with those of the 3
rd party cells (data not presented).
Supporting Information
Figure S1 Representative illustrations of CD4
+ and CD8
+ T cell
proliferative data in an immunized and tolerized subject shown in
Figures 3(A) and (B) of heterosexual subjects practising unprotect-
ed sex; included are autologous controls which were subtracted
from the values shown in Figures 3(A) and (B).
Found at: doi:10.1371/journal.pone.0007938.s001 (0.03 MB
PDF)
Figure S2 Representative illustration of CD4
+ and CD8
+ T cell
proliferative data in an immunized and tolerized subject shown in
Figures 3(C) and (D) from a heterosexual subjects practising
protected sex; included are autologous controls which were
subtracted from the values shown in Figures 3(C) and (D).
Found at: doi:10.1371/journal.pone.0007938.s002 (0.03 MB
PDF)
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